MIMS Education

Masked and White Coat Hypertension: Diagnosis and Management

Masked and White Coat Hypertension: Diagnosis and Management

CardiologyInternal MedicineFamily MedicineGeneral Practice
A badge with ribbon in color black 1 point | An analog clock in color black 1 hour | A black calendar with white triangle in center that has a black exclamation point in the middle 17 Apr 2024 


About this course

Hypertension remains to be a global health burden. Both the American College of Cardiology / American Heart Association (ACC/AHA) and European Society of Cardiology / European Society of Hypertension (ESC/ESH) recognizes the need for out-of-office blood pressure monitoring to identify both white coat hypertension or white coat syndrome and masked hypertension. While there is no hard evidence to show long-term benefit of treatment of white coat hypertension with hypertension-mediated organ damage (HMOD) and masked hypertension due to methodological issues in studies, there is a recognized increased CV risk in both entities that may need to be addressed.

This e-learning summarizes the diagnostic approach to masked and white coat hypertension, and reviews the data behind possible management options for these conditions.

Learning outcomes

Upon completion of the educational activity, participants should be able to:
  • Diagnose and manage white coat hypertension and masked hypertension.
  • Identify the different hypertensive-mediated organ damage (HMOD) markers.
  • Understand the value of out-of-office BP monitoring and hopefully integrate it into clinical practice.

Topics covered

  • Introduction
  • Diagnosing Hypertension
  • Masked vs White Coat Hypertension
  • To treat or not to treat: Management approach
Keywords: Hypertension, masked hypertension, white coat syndrome